Resultados de la búsqueda 941-950 of 5373 for Tetracycline ointment

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

  3. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to evaluate how well the combination of avelumab with liposomal doxorubicin with or without binimetinib, or the ...

  4. Oncología (médica) - Ensayos clínicos

    Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor ...

  5. Mayo Clinic

    Share · Tweet . VID-20312233. Inicio; YouTube - Introduction - Mayo Clinic Patient Video Guide - Minnesota. Tu donación es muy poderosa.

  6. Hematología - Ensayos clínicos

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  7. Oncología (médica) - Ensayos clínicos

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  8. Oncología (médica) - Ensayos clínicos

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  9. Cómo curar la piel agrietada en la punta del pulgar - Mayo Clinic

    También puede ser útil tratar la piel afectada con una crema más espesa a base de aceite o vaselina (Vaseline, Aquaphor Healing Ointment u otros) mientras ...

  10. Oncología (médica) - Ensayos clínicos

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...